HAE
Haemonetics Corporation
NYSE · Healthcare · Medical - Instruments & Supplies · US
$102.92
+0.07%Leverage
- Debt / equity
- 1.40x
- Net debt / equity
- 1.14x
- Debt / assets
- 0.50x
- Debt / EBITDA
- 4.50x
- Net debt / EBITDA
- 3.64x
Liquidity & coverage
- Current ratio
- 3.08x
- Quick ratio
- 1.91x
- Cash ratio
- 0.85x
- Interest coverage
- 8.03x
- EBITDA / interest
- 8.54x
- Working capital
- $547.6M
Cash & dividend
- FCF / debt
- 0.25x
- Cash flow / debt
- 0.28x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026